Hetero Biopharma Limited - Company Profile

Q: Who are the current directors of Hetero Biopharma Limited?

The current directors of Hetero Biopharma Limited are Bandi Vamsikrishna, Janardhan Katersala, Divyanshu Patidar, Govindaraju Bhavani, Parthasaradhi Reddy Bandi, Bhaskarreddy Pabbatireddy.

It is a pharma public limited company based in Balanagar, Telangana, India, established in 2016.

2016 Balanagar, Telangana, India Active

Last Updated: December 17, 2025

Access Report

About Hetero Biopharma Limited

Hetero Biopharma Limited, a active public limited company, was established on 14 September 2016 in Balanagar, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290TG2016PLC111946. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹166.00 Cr and a paid-up capital of ₹45.05 Cr.

It upholds a compliant status. Employing 486 professional, Its leadership includes Bandi Vamsikrishna (Director), Govindaraju Bhavani (Director), Parthasaradhi Reddy Bandi (Director). Past directors included Bhavesh Bansidhar Pujara, Bandi Vamsikrishna, Pankaj Jhawar. It holds ₹252.15 Cr open charges and no settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at #7-2-A2, Industrial Estate,, Sanath Nagar,, Balanagar, Telangana, 500018.

Company Details

CIN/LLPIN
U24290TG2016PLC111946
Registration Number
111946
Incorporation Date
14 September 2016
Authorized Capital
₹166.00 Cr
Paid-Up Capital
₹45.05 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 166.00 Cr as on 17-12-2025
Paid Up Capital ₹ 45.05 Cr as on 17-12-2025
Company Age 9 Year, 5 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 252.15 Cr as on 17-12-2025
Revenue Growth **** 13.44% (FY 2024)
Profit Growth **** -33.65% (FY 2024)
Ebitda **** -6.70% (FY 2024)
Net Worth 22.99% (FY 2024)
Total Assets **** 26.05% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Hetero Biopharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Hetero Biopharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Bandi Vamsikrishna	Director	25 Mar 2021	Current
Govindaraju Bhavani	Director	26 Aug 2022	Current
Parthasaradhi Reddy Bandi	Director	14 Sep 2016	Current
Bhaskarreddy Pabbatireddy	Additional Director	26 Sep 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	18 Sep 2024	Past
Pramod Abcsdd	Additional Director	29 Nov 2021	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Additional Director	14 Feb 2022	Past
Pramod Abcsdd	Additional Director	22 Sep 2022	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hetero Biopharma.

Hetero Biopharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 13.44% increase. The company also saw a substantial fall in profitability, with a 33.65% decrease in profit. The company's net worth Soared by an impressive increase of 22.99%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

13.44%

*******

Revenue from Operations

*******

13.81%

*******

Total Assets

*******

26.05%

*******

Profit or Loss

*******

-33.65%

*******

Net Worth

*******

22.99%

*******

EBITDA

*******

-6.70%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hetero Biopharma?

In 2024, Hetero Biopharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,521,493,423.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Sbicap Trustee Company Limited : 158.00 Cr
Others : 94.15 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Mar 2025	Sbicap Trustee Company Limited	₹75.00 Cr	Open
27 Mar 2025	Sbicap Trustee Company Limited	₹83.00 Cr	Open
14 Feb 2024	Others	₹2.50 M	Open
20 Feb 2023	Others	₹2.00 M	Open
07 Jun 2022	Others	₹9.79 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Hetero Biopharma?

Hetero Biopharma has a workforce of 486 employees as of Feb 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hetero Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetero Biopharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hetero Biopharma

Recent Activity within the Organization

Director Appointment

The activity Bhaskarreddy Pabbatireddy was appointed as a Additional Director was appointed as a Additional Director on 26 Sep 2025 & has been associated with this company since 5 months 6 days . was completed.
26 Sep 2025
Annual General Meeting

The activity Hetero Biopharma Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was completed.
28 Aug 2025
Balance Sheet

The activity Hetero Biopharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
31 Mar 2025
Charges

The activity A charge with Sbicap Trustee Company Limited amounted to Rs. 75.00 Cr with Charge ID 101078891 was registered on 27 Mar 2025. was completed.
27 Mar 2025
Charges

Progress on A charge with Sbicap Trustee Company Limited amounted to Rs. 83.00 Cr with Charge ID 101077053 was registered on 27 Mar 2025. was documented.
27 Mar 2025
Charges

Progress on A charge with Others of Rs. 92.72 Cr registered on 14 Sep 2021 with Charge ID 100482619 was modified on 17 Dec 2024. was documented.
17 Dec 2024

Explore recent activity and updates - View Recent Activity